Skip to Content

Notice

Manufacturer of Controlled Substances; Notice of Application

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 22, 2002, October 9, 2002, and November 7, 2002, Cody Laboratories, Inc., 331 33rd Street, Cody, Wyoming 82414, made application by three separate letters to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic class of Schedule I and II controlled substances listed below:

DrugSchedule
Dihydromorphine (9145)I
Methamphetamine (1105)II
Amphetamine (1100)II
Start Printed Page 16089
Amobarbital (2125)II
Pentobarbital (2270)II
Secobarbital (2315)II
Phenylacetone (8501)II
Oxycodone (9143)II

The firm plans to produce bulk product and finished dosage units for distribution to its customers.

Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: Drug Operations Section, Domestic Drug Unit (ODOD) and must be filed no later than June 2, 2003.

Start Signature

Dated: March 11, 2003.

Laura M. Nagel,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. 03-7825 Filed 4-1-03; 8:45 am]

BILLING CODE 4410-09-M